JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Exosomal miR-122-5p for regulation of secretory functions of fibroblasts and promotion of breast cancer metastasis by targeting MKP-2: an experimental study

  • 0Department of Medical Oncology, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Cancer Biology & Therapy +

|

May 4, 2025

|

May 4, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

Exosomes from breast cancer cells contain microRNA-122-5p (miR-122-5p) that promotes lung metastasis. This exosomal miR-122-5p enhances chemokine secretion in lung fibroblasts, aiding breast cancer cell colonization.

Area Of Science

  • Oncology
  • Molecular Biology
  • Cell Biology

Background

  • Tumor metastasis is a significant challenge in breast cancer treatment.
  • Exosomes, particularly exosomal microRNAs (miRNAs), are implicated in establishing pre-metastatic niches and promoting distant tumor spread.
  • Understanding the role of specific exosomal miRNAs in breast cancer metastasis is crucial for developing effective therapies.

Purpose Of The Study

  • To investigate the impact of exosomal miRNAs derived from breast cancer cells on metastasis.
  • To identify specific miRNAs involved in promoting breast cancer distant metastasis.
  • To elucidate the mechanism by which these exosomal miRNAs contribute to the metastatic process.

Main Methods

  • Exosomal miRNA isolation and sequencing from breast cancer patients and cell lines (MCF10A/MCF7/MDA-MB-231).
  • Quantitative real-time PCR (RT-PCR) to validate miRNA expression.
  • In vitro assays using miRNA mimics/inhibitors, luciferase assays, and Western blot to assess miRNA function and target interaction.
  • In vivo studies using xenograft mouse models to evaluate the effect on lung metastasis.

Main Results

  • Differential exosomal miRNAs from metastatic breast cancer patients showed higher expression in exosomes from MDA-MB-231 cells.
  • Exosomal miR-122-5p significantly enhanced the secretion of chemokines MCP-1 and SDF-1 from lung fibroblast cells (WI-38).
  • miR-122-5p directly targets the 3'-untranslated region of MKP-2, suppressing its expression in lung fibroblasts.
  • Administration of exosomal miR-122-5p to mice increased serum chemokine levels and promoted breast cancer lung metastasis.

Conclusions

  • Exosomal miR-122-5p derived from breast cancer cells plays a key role in promoting lung metastasis.
  • miR-122-5p facilitates breast cancer lung metastasis by inducing chemokine secretion from lung fibroblasts, thereby enhancing cancer cell chemotaxis and colonization.
  • Targeting exosomal miR-122-5p may represent a potential therapeutic strategy to inhibit breast cancer metastasis.

Keywords:

Related Concept Videos

MicroRNAs 01:22

21.0K

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...

Metastasis 02:30

5.4K

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Mitogens and the Cell Cycle 02:38

6.3K

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

The Tumor Microenvironment 02:17

6.4K

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

mTOR Signaling and Cancer Progression 03:03

3.6K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...